UK Single Cell Sequencing Market (2025-2030)
The UK Single Cell Sequencing Market was valued at $101.4 Million in 2025 and projected to reach to $186.5 Million by 2030, representing a compound annual growth rate of 13.0%. The UK single cell sequencing market is positioned for sustained expansion driven by increasing adoption in cancer research, immunology, and developmental biology applications.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Single Cell Sequencing Market Trends and Insights
- The UK's advanced healthcare infrastructure, strong research institutions, and significant investment in genomic technologies are driving adoption across academic and clinical settings.
- The UK benefits from a concentration of leading universities and NHS-affiliated research centers that are increasingly integrating single cell sequencing into cancer research, immunology, and regenerative medicine applications. Driving the UK market's 13.0% compound annual growth rate is the rising demand for precision medicine and personalized therapeutics.
- The UK's regulatory environment, including support from the UK Biobank and government funding initiatives, creates favorable conditions for single cell sequencing adoption.
- Healthcare providers and research organizations across the UK are investing in high-throughput sequencing capabilities to improve diagnostic accuracy and accelerate drug discovery pipelines. The UK market reflects broader European trends while maintaining distinct characteristics shaped by the National Health Service's research priorities and private sector innovation.
- Between 2025 and 2030, the UK is expected to consolidate its position as a leading European hub for single cell genomics research and clinical application..
Key Market Statistics
- CAGR (2025-2030) 13.0% CAGR
- Market Size, 2025 ~USD 101.4 Million
- Forecast, 2030 ~USD 186.5 Million
- Country UK
UK Single Cell Sequencing Market Overview
Market Valuation :
The UK single cell sequencing market is valued at $101.4 million in 2025, with strong growth trajectory reaching $186.5 million by 2030, representing a 13% CAGR.
Research Excellence :
The UK hosts world-leading research institutions including Oxford, Cambridge, and the Francis Crick Institute, driving significant adoption of single cell sequencing technologies in genomic research.
Healthcare Infrastructure :
The NHS and private healthcare sector's advanced infrastructure supports widespread implementation of single cell sequencing in clinical diagnostics and personalized medicine applications.
Government Investment :
UK government initiatives in genomic medicine and life sciences funding are accelerating adoption of single cell sequencing across academic medical centers and biotech companies.
UK Single Cell Sequencing Market Dynamics
- Leading academic institutions and NHS trusts are integrating single cell technologies into routine research and clinical workflows, supported by competitive funding landscapes and collaborative research networks.
- The market will benefit from growing demand for precision medicine and biomarker discovery across oncology and rare disease diagnostics.
- Continued investment in genomic infrastructure and skilled workforce development will further strengthen the UK's position as a hub for single cell sequencing innovation and commercialization..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The UK single cell sequencing market is valued at $101.4 million in 2025 and will reach $186.5 million by 2030, representing an 83.8% total growth over five years.
- The UK's 13.0% CAGR outpaces the global average of 12.2%, reflecting strong regional demand for precision medicine and genomic research capabilities.
- The UK's NHS infrastructure, world-class research institutions, and government funding support accelerated adoption of single cell sequencing technologies across clinical and academic sectors.
- Key growth drivers in the UK include rising cancer research investments, personalized medicine initiatives, and increasing collaboration between public healthcare systems and private biotech firms.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
UK Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 8.6 | 9.8 | 10.6 | 11.9 | 13.5 | 15.7 | 18.7 | 22.7 | 16.4 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 7.4 | 8.5 | 9.3 | 10.4 | 12 | 14 | 16.8 | 20.6 | 17.3 |
| HOSPITALS & CLINICAL LABORATORIES | 5.2 | 5.9 | 6.3 | 6.9 | 7.7 | 8.8 | 10.3 | 12.3 | 14.5 |
| TOTAL | 21.3 | 24.2 | 26.2 | 29.2 | 33.2 | 38.5 | 45.8 | 55.7 | 16.3 |
UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 31.17 | 31.45 | 32.14 | 34.19 | 37.5 | 42.18 | 48.39 | 56.43 | 11.9 |
| CROS | 7.66 | 7.63 | 7.7 | 8.09 | 8.76 | 9.73 | 11.01 | 12.68 | 10.5 |
| HOSPITALS & CLINICAL LABORATORIES | 14 | 14.01 | 14.2 | 14.98 | 16.3 | 18.18 | 20.68 | 23.92 | 11 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 20.39 | 20.65 | 21.18 | 22.6 | 24.87 | 28.07 | 32.31 | 37.81 | 12.3 |
| TOTAL | 73.22 | 73.74 | 75.23 | 79.86 | 87.43 | 98.16 | 112.39 | 130.84 | 11.7 |
Target Audience
- UK Biotech Companies : Single cell sequencing technology developers and service providers need UK market intelligence to identify growth opportunities, competitive positioning, and customer acquisition strategies in this high-growth segment.
- NHS and Hospital Trusts : Clinical laboratory directors and pathology leaders require market data to justify investment in single cell sequencing infrastructure and understand adoption trends across UK healthcare systems.
- Academic Research Institutions : University research centers and medical schools need market insights to secure funding, benchmark capabilities against peers, and align research programs with commercial opportunities.
- Pharmaceutical and Diagnostics Companies : Drug developers and in vitro diagnostics manufacturers require UK market analysis to identify partnership opportunities, customer needs, and commercial applications for single cell sequencing.
- Investment and Venture Capital Firms : UK-focused investors need comprehensive market data to evaluate investment opportunities, assess portfolio company performance, and identify emerging players in the single cell sequencing ecosystem.
Reasons to Buy this Report
- UK-Specific Market Sizing : Obtain precise market valuation data for the UK single cell sequencing sector with detailed 2025-2030 forecasts, enabling accurate investment and expansion planning for UK operations.
- Competitive Landscape Analysis : Understand the competitive positioning of UK-based and international players in the single cell sequencing market, identifying key players, partnerships, and market consolidation trends.
- NHS and Academic Adoption Insights : Gain intelligence on adoption rates across NHS trusts, university research centers, and private healthcare providers, critical for targeting clinical and research customer segments.
- Regulatory and Funding Environment : Access analysis of UK regulatory pathways, government funding initiatives, and reimbursement models shaping market dynamics and commercial opportunities in genomic medicine.
- Growth Driver Identification : Identify key growth catalysts specific to the UK market including emerging applications, technology trends, and strategic initiatives driving the 13% CAGR through 2030.
Frequently asked questions
What is the current market size of single cell sequencing in the UK?
The UK single cell sequencing market is valued at $101.4 million in 2025 and is projected to grow to $186.5 million by 2030.
What is the growth rate for single cell sequencing in the UK?
The UK market is growing at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030, outpacing the global average of 12.2%.
Which sectors are driving single cell sequencing adoption in the UK?
The UK's adoption is driven by cancer research, immunology studies, regenerative medicine, and precision medicine initiatives across NHS facilities and academic research centers.
How does the UK market compare to other European markets?
The UK's 13.0% CAGR and strong research infrastructure position it as a leading European market for single cell sequencing, supported by NHS funding and private sector innovation.
What factors support growth in the UK single cell sequencing market?
Key factors include government funding for genomic research, NHS adoption of precision medicine, collaboration between academic institutions and biotech companies, and increasing demand for personalized therapeutics.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
